7 studies were found.

1.		Recruiting	Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer Conditions: recurrent endometrial cancer; stage III endometrial cancer; stage IV endometrial cancer; endometrial papillary carcinoma
2.		Recruiting	Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer Conditions: stage III endometrial cancer; endometrial adenocarcinoma; endometrial adenosquamous cell carcinoma; endometrial adenoacanthoma; ...
3.		Recruiting	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer Conditions: stage III endometrial cancer; stage IV endometrial cancer; endometrial papillary carcinoma; endometrial clear cell carcinoma
4.		Recruiting	Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer Conditions: stage I endometrial cancer; stage II endometrial cancer; endometrial adenocarcinoma; endometrial papillary carcinoma; ...
5.		Recruiting	Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer Conditions: stage I endometrial cancer; stage II endometrial cancer; endometrial clear cell carcinoma; endometrial papillary carcinoma
6.		Recruiting	Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Endometrial Cancer Conditions: stage I endometrial cancer; stage II endometrial cancer; endometrial adenocarcinoma; endometrial adenosquamous cell carcinoma; ...
7.		Recruiting	CCI-779 in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer Condition: Endometrial Cancer